Related Experiment Video
Updated: Jul 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Association between atrial cardiopathy and stroke severity in acute ischemic stroke
Yidan Zhang1,2, Hanhan Lei3,4,5, Xiaomin Wu3,4,5
1The School of Clinical Medicine, Fujian Medical University, Fuzhou, 350122, China.
Insights
Atrial cardiopathy is linked to more severe acute ischemic strokes. This association persists even in patients without atrial fibrillation, highlighting a need for new stroke prevention strategies.
Area of Science:
- Cardiology
- Neurology
- Medical Research
Background:
- Atrial cardiopathy is a structural and functional abnormality of the left atrium.
- The relationship between atrial cardiopathy and acute ischemic stroke (AIS) severity requires further investigation, particularly independent of atrial fibrillation.
Purpose of the Study:
- To investigate the association between atrial cardiopathy and the initial severity of acute ischemic stroke (AIS).
- To determine if this association is independent of other cardiovascular conditions like atrial fibrillation and coronary artery disease.
Main Methods:
- Retrospective analysis of clinical data from 662 AIS patients (January 2017 - April 2023).
- Atrial cardiopathy defined by left atrial diameter, elevated P-wave terminal force in V1, or elevated N-terminal pro-B-type natriuretic peptide.
- Stroke severity assessed using the National Institutes of Health Stroke Scale (NIHSS); logistic regression used to analyze associations.
Main Results:
- 45.8% of AIS patients had atrial cardiopathy.
- Atrial cardiopathy was significantly associated with moderate-to-severe (aOR 2.16) and severe (aOR 4.89) AIS.
- The association remained significant after excluding patients with atrial fibrillation or coronary artery disease.
Conclusions:
- Atrial cardiopathy is independently associated with increased initial stroke severity in AIS patients.
- This finding holds true even in patients without atrial fibrillation.
- Further research is needed to develop targeted stroke prevention strategies for individuals with atrial cardiopathy.
Abstract:
In this hospital-based cross-sectional analytic study, we retrospectively reviewed clinical data of patients with acute ischemic stroke (AIS) between January 2017 and April 2023. Atrial cardiopathy was defined as any presence of the following: left atrial diameter ≥ 52 mm (males) or ≥ 47 mm (females), elevated P-wave terminal force in V1 > 5000 μV ms, or serum N terminal pro B type natriuretic peptide > 250 pg/ml. Initial stroke severity was defined by the National Institutes of Health Stroke Scale (NIHSS; moderate-to-severe, ≥ 5; and severe, ≥ 15). Univariate and multivariate binary logistic regression analyses were performed to assess the association between atrial cardiopathy and stroke severity. Among 662 AIS patients (mean age 70 years [interquartile range 61-78], 31.3% women), 303 (45.8%) had atrial cardiopathy. Multivariable logistic regression analysis showed that the presence of atrial cardiopathy was significantly associated with a higher odd of moderate-to-severe stroke (adjusted odds ratio [OR] 2.16, 95% confidence interval [CI] 1.46-3.20, p < 0.001) and severe stroke (adjusted OR 4.89, 95%CI 2.45-9.76, p < 0.001). This association remained significant in a sensitivity analysis excluding those with atrial fibrillation or coronary artery disease. Findings of the current study revealed that the association of atrial cardiopathy was with initial stroke severity independent of atrial fibrillation and was even confirmed in patients without atrial fibrillation; future studies to explore improved stroke prevention strategies for patients with atrial cardiopathy are needed.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology

